Preclinical Trial Equipment Supplied In Canada

Early-Stage Preclinical Program: 30% of all human malignancies display activating RAS mutations with another 60% showing over-activity of Ras-signaling pathways. BriaCell’s novel, proprietary PKCδ inhibitors have shown activity against multiple RAS transformed tumors. ...

easyTEL is a fully implantable telemetry system, that transmits physiological data from conscious freely moving small subjects weighing 20 g or more, single-housed. Intended for use in preclinical research, easyTEL-S size implants are ideal for mice and offer the ability to continuously record Biopotential (ECG, EEG, EMG, EOG)* , Core Body Temperature and ...

Neomem® FlexPlus is a single layer collagen membrane derived from porcine peritoneum. Suture pullout testing has shown this membrane to be biomechanically strong yet conformability evaluations demonstrate the ability to adapt to the contour of the surgical site. Neomem® FlexPlus hydrates quickly and handling characteristics make surgical placement easy. It can be repositioned easily and ...

Based on positive results from the preclinical research, we are ready to move forward with a clinical trial to see how well it works in humans. Clinical trials happen in several phases during which different questions are asked. Each phase builds on the results of previous ...

The system can manufacture between 10 mL and 10 L of formulation which allows researchers to use the Blaze for preclinical toxicology testing, and for early Chemistry, Manufacturing and Controls (CMC) ...

The Vevo® 3100 LT Imaging System is FUJIFILM VisualSonics’ entry-level micro-ultrasound product. It is perfectly suited for performing basic preclinical studies while meeting both your research and budgetary needs. The Vevo 3100 LT offers real-time, in vivo physiological information that contributes to understanding biological functions and so much ...

Theralase is laser focused on advancing the cutting-edge Anti-Cancer Therapy (“ACT”) towards commercialization, providing an alternative treatment methodology for Non-Muscle Invasive Bladder Cancer (“NMIBC”) patients globally. Theralase is dedicated to safely and effectively destroying cancer through the research, development and commercialization of light activated ...

emkaBATH is a type of tissue bath setup, designed for contractile measures in tissues such as aortic, tracheal, iliac, and papillary muscles, and/or microvessels such as veins, small arteries, and lymph vessels. The system provides heated, oxygenated, and nutrient-rich perfusate to the tissue with or without drug administration and electrical stimulation. Tissue baths are widely used to study the ...

The Enos surgical system is designed to deliver clinical capabilities beyond current robotic offerings. Titan engineers are designing the Enos system in direct response to feedback from laparoscopic and robotic assisted surgery device users. We are addressing an array of suggestions and requests ranging from device performance, ergonomics, operating room efficiency, ease of use, and reduced ...

Clinical testing on humans can only begin after a pre-clinical phase, involving laboratory studies (in vitro) and tests on animals, which has shown that the experimental drug is considered safe and effective. However, no animal is sufficiently similar to humans (even genetically modified ones) to make human testing unnecessary. For this reason, the experimental drug must also be tested on humans. ...

INM-755 is a cannabinol topical cream under development for the treatment of epidermolysis bullosa. INM-755 cream for EB is the first, and currently the only, cannabinol formulation being tested in clinical trials as a therapeutic ...

We aim to provide safe, dependable and lasting relief from allergy. We have developed a unique therapeutic approach based on a proprietary allergy vaccine technology to address the specific challenge of allergy (eBioparticle-Potentiated ...

INM-088 is a topical eye drop formulation under development for the treatment of glaucoma. The active pharmaceutical ingredient (API) in INM-088 is cannabinol, also known as CBN, a rare cannabinoid showing promise in its potential to provide neuroprotection and to reduce intraocular pressure of the ...

Mentanine®, supported by (cannabidiol “CBD” + IP formula) – molecules bond and synergistically attach to PPAR receptors allowing the formula to cross the blood-brain barrier (BBB) to target the central nervous system (the brain) with amplified effects and efficacy. CBD by itself did not do this in the pre-clinical trials. Mentanine® is a ...